Clayton Irvine, PharmD, MBA, MS, emphasized that optimizing value-based access to cell and gene therapies requires standardized care protocols, coordinated transitions between care settings, careful ...
Ryan Haumschild, PharmD, MS, MBA, discusses key considerations for pharmacists to ensure access to cutting-edge therapies for patients with cancer. Careful consideration of individual patient factors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback